Saudi Arabia Microbiology Cell Culture Market Scope and Market Size
Therefore, according to P&S Intelligence, the value of the Saudi Arabian microbiology cell culture market will likely increase from $29.8 million in 2017 to $38.7 million by 2023, at a 4.5% CAGR during 2018–2023 (forecast period).
The prevalence of tuberculosis (TB), invasive Streptococcus pneumoniae infection, malaria. Vommunity-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Extended-spectrum β-lactamase (ESBL) infection are rising in Saudi Arabia. As a result, the footfall at hospitals and diagnostic laboratories is increasing. Which is leading to a rise in microbiology cell culture activities. The process involves growing microbes in a controlled environment. So that the exact infection someone is suffering from can be identified.
Apart from healthcare firms, microbes are also cultured by academic and research institutes. Food and beverage companies. Pharmaceutical and biotechnology companies. Among these, the highest volume of such activities is witnessed in the pharmaceutical and biotechnology sector. As it is involved in the development of drugs for infectious diseases.
A key factor driving microbiology cell culture activities by such companies is the rising geriatric population (aged 65 years and above) in the kingdom. Which is set to grow from 1,169 thousand, or 3.4% of the total, in 2019 to 2,379 thousand. Or 6% of the total, by 2030, as per the United Nations (UN). The elderly have a weakened immune system. Which makes them an easier target for pathogens than younger people. Thus, with the increasing number of the elderly in the kingdom. The incidence of infectious diseases will rise, thereby propelling the demand for novel drugs.
This is also an important reason the Saudi government is pouring millions into the advancement of its life sciences sector. For instance, under the National Science, Technology and Innovation Plan (NSTIP), $373.0 million were spent by the King Abdulaziz City for Science and Technology (KACST) in 2016 to study a few rare conditions that are rising in prevalence in the Arabian region and come up with better diagnosis and treatment for non-communicable and communicable infections. An important aspect of the ensuing biotechnology research projects has been microbiology cell culture.
Saudi Arabia Microbiology Cell Culture Market Competitive Benchmarking
The bifurcations of the product segment of the Saudi Arabian microbiology cell culture market are instruments and consumables. Which the consumables bifurcation held the larger share during 2013–2017 (historical period). This is because instruments are generally a one-time purchase. Whereas the stocks of media, reagents, sera, and kits have to be replenished regularly. Thus, with the volume of such activities increasing in the kingdom on account of the growing cases of infectious diseases. The demand for consumables will rise as well.
Similarly, the instruments used for the purpose include cell culture supporting equipment. Bioreactors, cell culture storage equipment, and cell culture vessels. Among these, end users generate the highest demand for cell culture supporting equipment. Including filtration systems, CO2 incubators, centrifuges, cell counters, autoclaves, biosafety cabinets, microscopes, pipettes, needles, syringes, and pH meters. Apart from supporting equipment, the demand for cell culture vessels, such as roux bottles, multiwell plates, cell stacks, petri dishes, and flasks, is growing in the country.
Saudi Arabia Microbiology Cell Culture Market Historical Data & Forecasts
In 2017, the Saudi Arabian microbiology cell culture market was highly consolidated in nature. With just three companies holding the majority of the share. Bio-Rad Laboratories Inc., Merck KGaA, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Scharlab S.L., bioMérieux S.A., Hardy Diagnostics, Medical Disposable Manufacturing Company (MDM), Sara Medical Supplies Factory, Saudi Prepared Media Laboratory Limited Company, General Electric Company, and Diamond Microscope Est. are the major players in the market. To further augment their revenue. They are engaging in facility expansions and seeking regulatory approvals for products and technologies.
Hence, with the rising prevalence of infectious diseases in Saudi Arabia. The demand for various instruments and consumables used for culturing microbial cells will increase.
The Saudi Arabian microbiology cell culture market is expected to generate a revenue of $38.7 million by 2023. Increasing from $29.8 million in 2017. Progressing at a 4.5% CAGR during the forecast period (2018–2023).
The key factors leading to the growth of the market are the expanding life sciences market, increasing expenditure in the healthcare industry, surging prevalence of infectious diseases, technological advancements and regulatory approvals, and rising geriatric population. In terms of product, the market is divided into instruments and consumables.
The consumables division is further classified into reagents, media, and others, between which. The media classification accounted for the largest share (44.0%) of the Saudi Arabian microbiology cell culture market in 2017. The large value to volume ratio of these products is leading to the growth of this classification. The instruments division is further classified into cell culture supporting equipment, cell culture vessels, cell culture storage equipment, and bioreactors.
Saudi Arabia Microbiology Cell Culture Market Regional Opportunities
Out of these, the cell culture supporting equipment held the largest share of the market in 2017. When culture type is taken into consideration, the Saudi Arabian microbiology cell culture market is categorized into eukaryotic culture and bacterial culture, between which, the bacterial culture category accounted for the larger share of the market in 2017. Bacterial cell cultures are utilized majorly in Saudi Arabia, owing to their wider applications in various areas, as compared to eukaryotic cell culture.
On the basis of end user, the market is divided into academic & research institutes. Pharmaceutical & biotechnology companies, food & beverage companies, and others. Among all these, pharmaceutical & biotechnology companies dominated the market in the past. Holding a share of 44.3% in 2017. These companies are responsible for conducting a number of research activities in order to take forward the development of drugs. The demand for which is growing due to the surging prevalence of diseases and health conditions all over the globe.
Saudi Arabia Microbiology Cell Culture Market Latest Trends & Dynamics
The expansion of the life sciences sector in the country is a major driving factor of the Saudi Arabian microbiology cell culture market. The sector is registering growth due to the increasing spending in the healthcare industry and the country’s economic strength. King Abdulaziz City for Science and Technology spent $373.0 million in 2016 on health biotechnology research projects for studying certain rare conditions and for the diagnosis and treatment of non-communicable and communicable diseases in the region.
A key trend being witnessed in the Saudi Arabian microbiology cell culture market is automation in microbiology. Which is aiding in meeting the challenges of rising need for faster turnaround and surging test volumes in microbiology laboratories. The increasing application of laboratory interface systems and swift adoption of computer technology in laboratories enable the utilization of minimal sample volumes for results that are accurate. As per the NCBI (2014), MALDI-TOF MS was used by researcher for identifying new bacteria species in air samples from Makka, Saudi Arabia, during the Hajj.
Saudi Arabia Microbiology Cell Culture Market Industry Statistics
The life sciences sector is thriving in Saudi Arabia on account of the strengthening economy and rising healthcare expenditure. For instance, in 2016, King Abdulaziz City for Science and Technology (KACST) invested $373.0 million in health biotechnology research initiatives, under the National Science, Technology and Innovation Plan (NSTIP), to study some rare conditions in the region. The investment was essentially aimed at novel methods to diagnose and treat communicable and non-communicable diseases. Therefore, with the rising prevalence of infectious diseases in Saudi Arabia, the microbiology cell culture technology will advance in the coming years.
Apart from pharmaceutical and biotechnology firms. Microbiology cell culture also finds wide application with food and beverage companies and academic and research institutes. All of them opt for bacterial culture and eukaryotic culture to develop better-quality and safe products. For instance, food microbiologists use bacterial culture to ensure food safety and facilitate the economical production and distribution of food products. Furthermore, bacterial culture is used to diagnose blood, skin, and urine infections. By taking cell samples that are taken to a microbiology lab and placed in a special environment to encourage cell growth.
